# EDGAR Filing Document

**Accession Number:** 0001826729
**File Stem:** 0001104659-23-003899
**Filing Date:** 2023-1
**Character Count:** 2717
**Document Hash:** 8d62b82d23ff616f40d015d7b7bc9490
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-003899.hdr.sgml**: 20230117

**ACCESSION NUMBER**: 0001104659-23-003899

**CONFORMED SUBMISSION TYPE**: 15-12G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230117

**DATE AS OF CHANGE**: 20230113

**EFFECTIVENESS DATE**: 20230117

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EQ Health Acquisition Corp.
- **CENTRAL INDEX KEY:** 0001826729
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 852877347
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 15-12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39962
- **FILM NUMBER:** 23529783

**BUSINESS ADDRESS:**
- **STREET 1:** 4611 BEE CAVE RD. #106
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78746
- **BUSINESS PHONE:** 512.329.6977

**MAIL ADDRESS:**
- **STREET 1:** 4611 BEE CAVE RD. #106
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78746

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM 15** 

**CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION** 

**UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)** 

**OF THE SECURITIES EXCHANGE ACT OF 1934.** 

**Commission File Number: 001-39962**

**EQ HEALTH ACQUISITION CORP.**

**(Exact name of registrant as specified in its charter)** 

**4611 Bee Cave Road, Suite 213**

**Austin, TX 78731**

**(512) 329-6977**

**(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)** 

**Class A common stock, par value $0.0001 per share**

**Redeemable Warrants**

**(Title of each class of securities covered by this Form)** 

**None** 

**(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)** 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

---

| | |
|:---|:---|
| Rule 12g-4(a)(1) | x |
| Rule 12g-4(a)(2) | ◻ |
| Rule 12h-3(b)(1)(i) | ⌧ |
| Rule 12h-3(b)(1)(ii) | ◻ |
| Rule 15d-6 | ◻ |
| Rule 15-22(b) | ◻ |

---

Approximate number of holders of record as of the certification or notice date: 0

Pursuant to the requirements of the Securities Exchange Act of 1934, EQ Health Acquisition Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Dated: January 13, 2023

---

| | |
|:---|:---|
| EQ HEALTH ACQUISITION CORP. | EQ HEALTH ACQUISITION CORP. |
| By: | /s/ Scott Ellyson |
| Name: | Scott Ellyson |
| Title: | Chief Executive Officer |

---